NCT00114127View on ClinicalTrials.gov

Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome

PHASE3CompletedINTERVENTIONAL
Enrollment

28

Participants

Timeline

Start Date

June 30, 2004

Primary Completion Date

November 30, 2008

Study Completion Date

July 31, 2010

Conditions
Anxiety Disorder
Interventions
DRUG

Duloxetine

60 mg duloxetine 1x per day

DRUG

Duloxetine

60 mg duloxetine 1x per day + 60mg duloxetine 1x per day

DRUG

Placebo

60mg placebo 1x per day

Trial Locations (1)

02114

Massachusetts General Hospital, Boston

All Listed Sponsors
lead

Massachusetts General Hospital

OTHER

NCT00114127 - Duloxetine for Social Anxiety Disorder: Prediction of Long Term Outcome | Biotech Hunter | Biotech Hunter